nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.339	1	CrCtD
Cyclobenzaprine—HTR2A—epilepsy syndrome	0.0724	0.522	CbGaD
Cyclobenzaprine—CYP2D6—epilepsy syndrome	0.0663	0.478	CbGaD
Cyclobenzaprine—Protriptyline—Carbamazepine—epilepsy syndrome	0.0173	0.0688	CrCrCtD
Cyclobenzaprine—Indecainide—Oxcarbazepine—epilepsy syndrome	0.015	0.0597	CrCrCtD
Cyclobenzaprine—Phenindione—Fosphenytoin—epilepsy syndrome	0.0148	0.0589	CrCrCtD
Cyclobenzaprine—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.0133	0.053	CrCrCtD
Cyclobenzaprine—Carbamazepine—Phenytoin—epilepsy syndrome	0.0123	0.0489	CrCrCtD
Cyclobenzaprine—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.0105	0.0416	CrCrCtD
Cyclobenzaprine—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.0105	0.0416	CrCrCtD
Cyclobenzaprine—Phenindione—Phenytoin—epilepsy syndrome	0.0101	0.0404	CrCrCtD
Cyclobenzaprine—CYP1A2—Carbamazepine—epilepsy syndrome	0.01	0.0662	CbGbCtD
Cyclobenzaprine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.00944	0.0376	CrCrCtD
Cyclobenzaprine—Phenindione—Carbamazepine—epilepsy syndrome	0.00936	0.0372	CrCrCtD
Cyclobenzaprine—CYP1A2—Primidone—epilepsy syndrome	0.00936	0.0618	CbGbCtD
Cyclobenzaprine—Phenindione—Oxcarbazepine—epilepsy syndrome	0.00863	0.0343	CrCrCtD
Cyclobenzaprine—CYP1A2—Propofol—epilepsy syndrome	0.00839	0.0554	CbGbCtD
Cyclobenzaprine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00837	0.0552	CbGbCtD
Cyclobenzaprine—Phenindione—Clobazam—epilepsy syndrome	0.00827	0.0329	CrCrCtD
Cyclobenzaprine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00802	0.0529	CbGbCtD
Cyclobenzaprine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00795	0.0316	CrCrCtD
Cyclobenzaprine—Trimipramine—Carbamazepine—epilepsy syndrome	0.00783	0.0312	CrCrCtD
Cyclobenzaprine—CYP3A4—Felbamate—epilepsy syndrome	0.00778	0.0513	CbGbCtD
Cyclobenzaprine—CYP3A4—Trimethadione—epilepsy syndrome	0.00778	0.0513	CbGbCtD
Cyclobenzaprine—CYP1A2—Diazepam—epilepsy syndrome	0.0076	0.0502	CbGbCtD
Cyclobenzaprine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.00749	0.0298	CrCrCtD
Cyclobenzaprine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00731	0.0483	CbGbCtD
Cyclobenzaprine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00722	0.0287	CrCrCtD
Cyclobenzaprine—Imipramine—Carbamazepine—epilepsy syndrome	0.00718	0.0286	CrCrCtD
Cyclobenzaprine—CYP2D6—Propofol—epilepsy syndrome	0.00691	0.0456	CbGbCtD
Cyclobenzaprine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0069	0.0275	CrCrCtD
Cyclobenzaprine—Promethazine—Carbamazepine—epilepsy syndrome	0.00664	0.0264	CrCrCtD
Cyclobenzaprine—Chlorprothixene—Midazolam—epilepsy syndrome	0.00662	0.0263	CrCrCtD
Cyclobenzaprine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00662	0.0263	CrCrCtD
Cyclobenzaprine—CYP3A4—Clonazepam—epilepsy syndrome	0.00661	0.0437	CbGbCtD
Cyclobenzaprine—Alimemazine—Carbamazepine—epilepsy syndrome	0.00652	0.0259	CrCrCtD
Cyclobenzaprine—Benzphetamine—Phenytoin—epilepsy syndrome	0.00638	0.0254	CrCrCtD
Cyclobenzaprine—CYP3A4—Clobazam—epilepsy syndrome	0.00634	0.0419	CbGbCtD
Cyclobenzaprine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00612	0.0243	CrCrCtD
Cyclobenzaprine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00601	0.0239	CrCrCtD
Cyclobenzaprine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00599	0.0395	CbGbCtD
Cyclobenzaprine—Chlorprothixene—Diazepam—epilepsy syndrome	0.0059	0.0235	CrCrCtD
Cyclobenzaprine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00567	0.0225	CrCrCtD
Cyclobenzaprine—Promazine—Carbamazepine—epilepsy syndrome	0.00562	0.0224	CrCrCtD
Cyclobenzaprine—CYP3A4—Rufinamide—epilepsy syndrome	0.00539	0.0356	CbGbCtD
Cyclobenzaprine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00525	0.0347	CbGbCtD
Cyclobenzaprine—Promazine—Oxcarbazepine—epilepsy syndrome	0.00518	0.0206	CrCrCtD
Cyclobenzaprine—CYP3A4—Primidone—epilepsy syndrome	0.0049	0.0324	CbGbCtD
Cyclobenzaprine—CYP3A4—Phenytoin—epilepsy syndrome	0.00471	0.0311	CbGbCtD
Cyclobenzaprine—CYP3A4—Propofol—epilepsy syndrome	0.00439	0.029	CbGbCtD
Cyclobenzaprine—CYP3A4—Acetazolamide—epilepsy syndrome	0.0042	0.0277	CbGbCtD
Cyclobenzaprine—CYP3A4—Phenobarbital—epilepsy syndrome	0.0042	0.0277	CbGbCtD
Cyclobenzaprine—CYP3A4—Midazolam—epilepsy syndrome	0.00414	0.0273	CbGbCtD
Cyclobenzaprine—CYP3A4—Diazepam—epilepsy syndrome	0.00398	0.0263	CbGbCtD
Cyclobenzaprine—CYP3A4—Zonisamide—epilepsy syndrome	0.00389	0.0257	CbGbCtD
Cyclobenzaprine—HTR2A—phrenic nerve—epilepsy syndrome	0.00368	0.254	CbGeAlD
Cyclobenzaprine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00314	0.0207	CbGbCtD
Cyclobenzaprine—CYP3A4—Topiramate—epilepsy syndrome	0.00283	0.0187	CbGbCtD
Cyclobenzaprine—HTR2A—locus ceruleus—epilepsy syndrome	0.00164	0.114	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00134	0.0926	CbGeAlD
Cyclobenzaprine—HTR2A—vagus nerve—epilepsy syndrome	0.00126	0.087	CbGeAlD
Cyclobenzaprine—HTR2A—pons—epilepsy syndrome	0.000948	0.0655	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000874	0.0604	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00078	0.0539	CbGeAlD
Cyclobenzaprine—HTR2A—ganglion—epilepsy syndrome	0.000485	0.0335	CbGeAlD
Cyclobenzaprine—HTR2A—hindbrain—epilepsy syndrome	0.000368	0.0254	CbGeAlD
Cyclobenzaprine—CYP2D6—hindbrain—epilepsy syndrome	0.000335	0.0232	CbGeAlD
Cyclobenzaprine—HTR2A—brainstem—epilepsy syndrome	0.000211	0.0146	CbGeAlD
Cyclobenzaprine—HTR2A—forebrain—epilepsy syndrome	0.000204	0.0141	CbGeAlD
Cyclobenzaprine—CYP2D6—brainstem—epilepsy syndrome	0.000192	0.0133	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalon—epilepsy syndrome	0.000187	0.0129	CbGeAlD
Cyclobenzaprine—CYP2D6—forebrain—epilepsy syndrome	0.000186	0.0128	CbGeAlD
Cyclobenzaprine—CYP2D6—telencephalon—epilepsy syndrome	0.000171	0.0118	CbGeAlD
Cyclobenzaprine—Olopatadine—S100B—epilepsy syndrome	0.000164	0.0717	CrCbGaD
Cyclobenzaprine—HTR2A—medulla oblongata—epilepsy syndrome	0.000147	0.0102	CbGeAlD
Cyclobenzaprine—HTR2A—midbrain—epilepsy syndrome	0.000134	0.00929	CbGeAlD
Cyclobenzaprine—HTR2A—spinal cord—epilepsy syndrome	0.000131	0.00906	CbGeAlD
Cyclobenzaprine—HTR2A—head—epilepsy syndrome	0.000117	0.00805	CbGeAlD
Cyclobenzaprine—HTR2A—nervous system—epilepsy syndrome	0.000111	0.00764	CbGeAlD
Cyclobenzaprine—HTR2A—central nervous system—epilepsy syndrome	0.000106	0.00735	CbGeAlD
Cyclobenzaprine—CYP2D6—head—epilepsy syndrome	0.000106	0.00734	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellum—epilepsy syndrome	0.000104	0.00719	CbGeAlD
Cyclobenzaprine—CYP3A4—nervous system—epilepsy syndrome	0.000102	0.00707	CbGeAlD
Cyclobenzaprine—CYP2D6—nervous system—epilepsy syndrome	0.000101	0.00696	CbGeAlD
Cyclobenzaprine—CYP3A4—central nervous system—epilepsy syndrome	9.85e-05	0.00681	CbGeAlD
Cyclobenzaprine—CYP2D6—central nervous system—epilepsy syndrome	9.7e-05	0.0067	CbGeAlD
Cyclobenzaprine—CYP2D6—cerebellum—epilepsy syndrome	9.48e-05	0.00655	CbGeAlD
Cyclobenzaprine—HTR2A—brain—epilepsy syndrome	8.45e-05	0.00584	CbGeAlD
Cyclobenzaprine—Carbamazepine—SCN9A—epilepsy syndrome	7.98e-05	0.0348	CrCbGaD
Cyclobenzaprine—CYP2D6—brain—epilepsy syndrome	7.7e-05	0.00532	CbGeAlD
Cyclobenzaprine—Imipramine—KCND2—epilepsy syndrome	7.48e-05	0.0326	CrCbGaD
Cyclobenzaprine—Amitriptyline—KCND2—epilepsy syndrome	7.44e-05	0.0324	CrCbGaD
Cyclobenzaprine—Carbamazepine—SCN4A—epilepsy syndrome	7.33e-05	0.0319	CrCbGaD
Cyclobenzaprine—Amitriptyline—KCNQ2—epilepsy syndrome	6.91e-05	0.0301	CrCbGaD
Cyclobenzaprine—Amitriptyline—KCNQ3—epilepsy syndrome	6.91e-05	0.0301	CrCbGaD
Cyclobenzaprine—Doxylamine—CHRM1—epilepsy syndrome	6.77e-05	0.0295	CrCbGaD
Cyclobenzaprine—Amitriptyline—NTRK2—epilepsy syndrome	5.88e-05	0.0256	CrCbGaD
Cyclobenzaprine—Orphenadrine—SCN9A—epilepsy syndrome	5.74e-05	0.025	CrCbGaD
Cyclobenzaprine—Orphenadrine—SCN4A—epilepsy syndrome	5.28e-05	0.023	CrCbGaD
Cyclobenzaprine—Dimetindene—CHRM2—epilepsy syndrome	4.83e-05	0.0211	CrCbGaD
Cyclobenzaprine—Cyproheptadine—CHRM3—epilepsy syndrome	4.35e-05	0.019	CrCbGaD
Cyclobenzaprine—Cyproheptadine—CHRM1—epilepsy syndrome	4.06e-05	0.0177	CrCbGaD
Cyclobenzaprine—Orphenadrine—SCN1A—epilepsy syndrome	3.86e-05	0.0168	CrCbGaD
Cyclobenzaprine—Protriptyline—SLC6A4—epilepsy syndrome	3.81e-05	0.0166	CrCbGaD
Cyclobenzaprine—Cyproheptadine—CHRM2—epilepsy syndrome	3.31e-05	0.0144	CrCbGaD
Cyclobenzaprine—Chlorprothixene—CHRM3—epilepsy syndrome	3e-05	0.0131	CrCbGaD
Cyclobenzaprine—Nortriptyline—CHRM3—epilepsy syndrome	2.95e-05	0.0128	CrCbGaD
Cyclobenzaprine—Chlorprothixene—CHRM1—epilepsy syndrome	2.8e-05	0.0122	CrCbGaD
Cyclobenzaprine—Nortriptyline—CHRM1—epilepsy syndrome	2.75e-05	0.012	CrCbGaD
Cyclobenzaprine—Protriptyline—CYP2D6—epilepsy syndrome	2.68e-05	0.0117	CrCbGaD
Cyclobenzaprine—Promethazine—CHRM3—epilepsy syndrome	2.67e-05	0.0116	CrCbGaD
Cyclobenzaprine—Doxepin—CHRM3—epilepsy syndrome	2.64e-05	0.0115	CrCbGaD
Cyclobenzaprine—Promethazine—CHRM1—epilepsy syndrome	2.49e-05	0.0109	CrCbGaD
Cyclobenzaprine—Doxepin—CHRM1—epilepsy syndrome	2.47e-05	0.0107	CrCbGaD
Cyclobenzaprine—Carbamazepine—ABCC2—epilepsy syndrome	2.42e-05	0.0105	CrCbGaD
Cyclobenzaprine—Tripelennamine—CYP2D6—epilepsy syndrome	2.41e-05	0.0105	CrCbGaD
Cyclobenzaprine—Amitriptyline—OPRD1—epilepsy syndrome	2.41e-05	0.0105	CrCbGaD
Cyclobenzaprine—Promazine—CHRM3—epilepsy syndrome	2.35e-05	0.0102	CrCbGaD
Cyclobenzaprine—Asthenia—Clonazepam—epilepsy syndrome	2.32e-05	0.000255	CcSEcCtD
Cyclobenzaprine—Headache—Fosphenytoin—epilepsy syndrome	2.32e-05	0.000254	CcSEcCtD
Cyclobenzaprine—Hepatitis—Topiramate—epilepsy syndrome	2.32e-05	0.000254	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.31e-05	0.000254	CcSEcCtD
Cyclobenzaprine—Palpitations—Pregabalin—epilepsy syndrome	2.31e-05	0.000254	CcSEcCtD
Cyclobenzaprine—Asthenia—Phenytoin—epilepsy syndrome	2.31e-05	0.000254	CcSEcCtD
Cyclobenzaprine—Nausea—Midazolam—epilepsy syndrome	2.3e-05	0.000253	CcSEcCtD
Cyclobenzaprine—Hallucination—Topiramate—epilepsy syndrome	2.3e-05	0.000253	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Topiramate—epilepsy syndrome	2.3e-05	0.000253	CcSEcCtD
Cyclobenzaprine—Tachycardia—Valproic Acid—epilepsy syndrome	2.3e-05	0.000253	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Zonisamide—epilepsy syndrome	2.3e-05	0.000253	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Topiramate—epilepsy syndrome	2.3e-05	0.000252	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.3e-05	0.000252	CcSEcCtD
Cyclobenzaprine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.3e-05	0.000252	CcSEcCtD
Cyclobenzaprine—Pruritus—Clonazepam—epilepsy syndrome	2.29e-05	0.000252	CcSEcCtD
Cyclobenzaprine—Vomiting—Vigabatrin—epilepsy syndrome	2.29e-05	0.000252	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—CHRM2—epilepsy syndrome	2.29e-05	0.00996	CrCbGaD
Cyclobenzaprine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.28e-05	0.00025	CcSEcCtD
Cyclobenzaprine—Pruritus—Phenytoin—epilepsy syndrome	2.28e-05	0.00025	CcSEcCtD
Cyclobenzaprine—Nausea—Levetiracetam—epilepsy syndrome	2.28e-05	0.00025	CcSEcCtD
Cyclobenzaprine—Rash—Vigabatrin—epilepsy syndrome	2.27e-05	0.00025	CcSEcCtD
Cyclobenzaprine—Dizziness—Felbamate—epilepsy syndrome	2.27e-05	0.000249	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vigabatrin—epilepsy syndrome	2.27e-05	0.000249	CcSEcCtD
Cyclobenzaprine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.26e-05	0.000249	CcSEcCtD
Cyclobenzaprine—Convulsion—Pregabalin—epilepsy syndrome	2.26e-05	0.000249	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.26e-05	0.000249	CcSEcCtD
Cyclobenzaprine—Vision blurred—Gabapentin—epilepsy syndrome	2.26e-05	0.000248	CcSEcCtD
Cyclobenzaprine—Headache—Vigabatrin—epilepsy syndrome	2.26e-05	0.000248	CcSEcCtD
Cyclobenzaprine—Hypertension—Pregabalin—epilepsy syndrome	2.26e-05	0.000248	CcSEcCtD
Cyclobenzaprine—Vomiting—Diazepam—epilepsy syndrome	2.26e-05	0.000248	CcSEcCtD
Cyclobenzaprine—Anorexia—Valproic Acid—epilepsy syndrome	2.25e-05	0.000247	CcSEcCtD
Cyclobenzaprine—Tremor—Gabapentin—epilepsy syndrome	2.24e-05	0.000247	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CHRM2—epilepsy syndrome	2.24e-05	0.00978	CrCbGaD
Cyclobenzaprine—Rash—Diazepam—epilepsy syndrome	2.24e-05	0.000246	CcSEcCtD
Cyclobenzaprine—Dermatitis—Diazepam—epilepsy syndrome	2.24e-05	0.000245	CcSEcCtD
Cyclobenzaprine—Chest pain—Pregabalin—epilepsy syndrome	2.22e-05	0.000244	CcSEcCtD
Cyclobenzaprine—Myalgia—Pregabalin—epilepsy syndrome	2.22e-05	0.000244	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.22e-05	0.000244	CcSEcCtD
Cyclobenzaprine—Dizziness—Zonisamide—epilepsy syndrome	2.22e-05	0.000244	CcSEcCtD
Cyclobenzaprine—Headache—Diazepam—epilepsy syndrome	2.22e-05	0.000244	CcSEcCtD
Cyclobenzaprine—Anxiety—Pregabalin—epilepsy syndrome	2.22e-05	0.000243	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Clonazepam—epilepsy syndrome	2.22e-05	0.000243	CcSEcCtD
Cyclobenzaprine—Benzphetamine—ADRA2A—epilepsy syndrome	2.21e-05	0.00963	CrCbGaD
Cyclobenzaprine—Hypotension—Valproic Acid—epilepsy syndrome	2.2e-05	0.000242	CcSEcCtD
Cyclobenzaprine—Asthenia—Carbamazepine—epilepsy syndrome	2.2e-05	0.000242	CcSEcCtD
Cyclobenzaprine—Agitation—Gabapentin—epilepsy syndrome	2.2e-05	0.000242	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Phenytoin—epilepsy syndrome	2.2e-05	0.000242	CcSEcCtD
Cyclobenzaprine—Discomfort—Pregabalin—epilepsy syndrome	2.2e-05	0.000241	CcSEcCtD
Cyclobenzaprine—Nausea—Fosphenytoin—epilepsy syndrome	2.2e-05	0.000241	CcSEcCtD
Cyclobenzaprine—Promazine—CHRM1—epilepsy syndrome	2.19e-05	0.00955	CrCbGaD
Cyclobenzaprine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.19e-05	0.000241	CcSEcCtD
Cyclobenzaprine—Angioedema—Gabapentin—epilepsy syndrome	2.19e-05	0.00024	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.19e-05	0.00024	CcSEcCtD
Cyclobenzaprine—Vomiting—Felbamate—epilepsy syndrome	2.18e-05	0.00024	CcSEcCtD
Cyclobenzaprine—Dry mouth—Pregabalin—epilepsy syndrome	2.18e-05	0.000239	CcSEcCtD
Cyclobenzaprine—Pruritus—Carbamazepine—epilepsy syndrome	2.17e-05	0.000239	CcSEcCtD
Cyclobenzaprine—Rash—Felbamate—epilepsy syndrome	2.17e-05	0.000238	CcSEcCtD
Cyclobenzaprine—Dermatitis—Felbamate—epilepsy syndrome	2.16e-05	0.000238	CcSEcCtD
Cyclobenzaprine—Malaise—Gabapentin—epilepsy syndrome	2.16e-05	0.000237	CcSEcCtD
Cyclobenzaprine—Tinnitus—Topiramate—epilepsy syndrome	2.16e-05	0.000237	CcSEcCtD
Cyclobenzaprine—Vertigo—Gabapentin—epilepsy syndrome	2.15e-05	0.000236	CcSEcCtD
Cyclobenzaprine—Headache—Felbamate—epilepsy syndrome	2.15e-05	0.000236	CcSEcCtD
Cyclobenzaprine—Confusional state—Pregabalin—epilepsy syndrome	2.15e-05	0.000236	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.15e-05	0.000236	CcSEcCtD
Cyclobenzaprine—Syncope—Gabapentin—epilepsy syndrome	2.15e-05	0.000236	CcSEcCtD
Cyclobenzaprine—Leukopenia—Gabapentin—epilepsy syndrome	2.14e-05	0.000236	CcSEcCtD
Cyclobenzaprine—Dizziness—Clonazepam—epilepsy syndrome	2.14e-05	0.000235	CcSEcCtD
Cyclobenzaprine—Nausea—Vigabatrin—epilepsy syndrome	2.14e-05	0.000235	CcSEcCtD
Cyclobenzaprine—Vomiting—Zonisamide—epilepsy syndrome	2.14e-05	0.000235	CcSEcCtD
Cyclobenzaprine—Insomnia—Valproic Acid—epilepsy syndrome	2.13e-05	0.000234	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.13e-05	0.000234	CcSEcCtD
Cyclobenzaprine—Oedema—Pregabalin—epilepsy syndrome	2.13e-05	0.000234	CcSEcCtD
Cyclobenzaprine—Asthenia—Lamotrigine—epilepsy syndrome	2.13e-05	0.000234	CcSEcCtD
Cyclobenzaprine—Dizziness—Phenytoin—epilepsy syndrome	2.13e-05	0.000234	CcSEcCtD
Cyclobenzaprine—Rash—Zonisamide—epilepsy syndrome	2.12e-05	0.000233	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.12e-05	0.000233	CcSEcCtD
Cyclobenzaprine—Palpitations—Gabapentin—epilepsy syndrome	2.12e-05	0.000233	CcSEcCtD
Cyclobenzaprine—Dermatitis—Zonisamide—epilepsy syndrome	2.12e-05	0.000233	CcSEcCtD
Cyclobenzaprine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.12e-05	0.000232	CcSEcCtD
Cyclobenzaprine—Nausea—Diazepam—epilepsy syndrome	2.11e-05	0.000231	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.11e-05	0.000231	CcSEcCtD
Cyclobenzaprine—Headache—Zonisamide—epilepsy syndrome	2.11e-05	0.000231	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.1e-05	0.000231	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.1e-05	0.000231	CcSEcCtD
Cyclobenzaprine—Pruritus—Lamotrigine—epilepsy syndrome	2.1e-05	0.000231	CcSEcCtD
Cyclobenzaprine—Shock—Pregabalin—epilepsy syndrome	2.1e-05	0.00023	CcSEcCtD
Cyclobenzaprine—Somnolence—Valproic Acid—epilepsy syndrome	2.1e-05	0.00023	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.09e-05	0.000229	CcSEcCtD
Cyclobenzaprine—Tachycardia—Pregabalin—epilepsy syndrome	2.08e-05	0.000229	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.08e-05	0.000228	CcSEcCtD
Cyclobenzaprine—Convulsion—Gabapentin—epilepsy syndrome	2.08e-05	0.000228	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—CHRM2—epilepsy syndrome	2.08e-05	0.00904	CrCbGaD
Cyclobenzaprine—Hypertension—Gabapentin—epilepsy syndrome	2.07e-05	0.000227	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.06e-05	0.000226	CcSEcCtD
Cyclobenzaprine—Vomiting—Clonazepam—epilepsy syndrome	2.06e-05	0.000226	CcSEcCtD
Cyclobenzaprine—Imipramine—CHRM3—epilepsy syndrome	2.06e-05	0.00897	CrCbGaD
Cyclobenzaprine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.05e-05	0.000225	CcSEcCtD
Cyclobenzaprine—Alopecia—Topiramate—epilepsy syndrome	2.05e-05	0.000225	CcSEcCtD
Cyclobenzaprine—Vomiting—Phenytoin—epilepsy syndrome	2.05e-05	0.000225	CcSEcCtD
Cyclobenzaprine—Amitriptyline—CHRM3—epilepsy syndrome	2.05e-05	0.00891	CrCbGaD
Cyclobenzaprine—Rash—Clonazepam—epilepsy syndrome	2.04e-05	0.000224	CcSEcCtD
Cyclobenzaprine—Dermatitis—Clonazepam—epilepsy syndrome	2.04e-05	0.000224	CcSEcCtD
Cyclobenzaprine—Chest pain—Gabapentin—epilepsy syndrome	2.04e-05	0.000224	CcSEcCtD
Cyclobenzaprine—Myalgia—Gabapentin—epilepsy syndrome	2.04e-05	0.000224	CcSEcCtD
Cyclobenzaprine—Nausea—Felbamate—epilepsy syndrome	2.04e-05	0.000224	CcSEcCtD
Cyclobenzaprine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.000224	CcSEcCtD
Cyclobenzaprine—Promethazine—CHRM2—epilepsy syndrome	2.03e-05	0.00887	CrCbGaD
Cyclobenzaprine—Fatigue—Valproic Acid—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Anxiety—Gabapentin—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Anorexia—Pregabalin—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Dizziness—Carbamazepine—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Headache—Clonazepam—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Rash—Phenytoin—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Dermatitis—Phenytoin—epilepsy syndrome	2.03e-05	0.000223	CcSEcCtD
Cyclobenzaprine—Rash—Oxcarbazepine—epilepsy syndrome	2.02e-05	0.000222	CcSEcCtD
Cyclobenzaprine—Constipation—Valproic Acid—epilepsy syndrome	2.02e-05	0.000222	CcSEcCtD
Cyclobenzaprine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.02e-05	0.000221	CcSEcCtD
Cyclobenzaprine—Headache—Phenytoin—epilepsy syndrome	2.02e-05	0.000221	CcSEcCtD
Cyclobenzaprine—Discomfort—Gabapentin—epilepsy syndrome	2.02e-05	0.000221	CcSEcCtD
Cyclobenzaprine—Doxepin—CHRM2—epilepsy syndrome	2.01e-05	0.00878	CrCbGaD
Cyclobenzaprine—Headache—Oxcarbazepine—epilepsy syndrome	2.01e-05	0.00022	CcSEcCtD
Cyclobenzaprine—Nausea—Zonisamide—epilepsy syndrome	2e-05	0.000219	CcSEcCtD
Cyclobenzaprine—Dry mouth—Gabapentin—epilepsy syndrome	2e-05	0.000219	CcSEcCtD
Cyclobenzaprine—Hypotension—Pregabalin—epilepsy syndrome	1.99e-05	0.000219	CcSEcCtD
Cyclobenzaprine—Flatulence—Topiramate—epilepsy syndrome	1.99e-05	0.000218	CcSEcCtD
Cyclobenzaprine—Tension—Topiramate—epilepsy syndrome	1.98e-05	0.000217	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Topiramate—epilepsy syndrome	1.97e-05	0.000217	CcSEcCtD
Cyclobenzaprine—Confusional state—Gabapentin—epilepsy syndrome	1.97e-05	0.000217	CcSEcCtD
Cyclobenzaprine—Dizziness—Lamotrigine—epilepsy syndrome	1.96e-05	0.000216	CcSEcCtD
Cyclobenzaprine—Orphenadrine—CHRM2—epilepsy syndrome	1.96e-05	0.00855	CrCbGaD
Cyclobenzaprine—Nervousness—Topiramate—epilepsy syndrome	1.96e-05	0.000215	CcSEcCtD
Cyclobenzaprine—Oedema—Gabapentin—epilepsy syndrome	1.96e-05	0.000215	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.96e-05	0.000215	CcSEcCtD
Cyclobenzaprine—Vomiting—Carbamazepine—epilepsy syndrome	1.95e-05	0.000214	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.94e-05	0.000214	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.94e-05	0.000213	CcSEcCtD
Cyclobenzaprine—Rash—Carbamazepine—epilepsy syndrome	1.94e-05	0.000213	CcSEcCtD
Cyclobenzaprine—Dermatitis—Carbamazepine—epilepsy syndrome	1.93e-05	0.000213	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.93e-05	0.000212	CcSEcCtD
Cyclobenzaprine—Insomnia—Pregabalin—epilepsy syndrome	1.93e-05	0.000212	CcSEcCtD
Cyclobenzaprine—Nausea—Clonazepam—epilepsy syndrome	1.92e-05	0.000211	CcSEcCtD
Cyclobenzaprine—Headache—Carbamazepine—epilepsy syndrome	1.92e-05	0.000211	CcSEcCtD
Cyclobenzaprine—Shock—Gabapentin—epilepsy syndrome	1.92e-05	0.000211	CcSEcCtD
Cyclobenzaprine—Imipramine—CHRM1—epilepsy syndrome	1.92e-05	0.00836	CrCbGaD
Cyclobenzaprine—Paraesthesia—Pregabalin—epilepsy syndrome	1.92e-05	0.00021	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.91e-05	0.00021	CcSEcCtD
Cyclobenzaprine—Protriptyline—ABCB1—epilepsy syndrome	1.91e-05	0.00834	CrCbGaD
Cyclobenzaprine—Nausea—Phenytoin—epilepsy syndrome	1.91e-05	0.00021	CcSEcCtD
Cyclobenzaprine—Tachycardia—Gabapentin—epilepsy syndrome	1.91e-05	0.00021	CcSEcCtD
Cyclobenzaprine—Amitriptyline—CHRM1—epilepsy syndrome	1.91e-05	0.00831	CrCbGaD
Cyclobenzaprine—Dyspnoea—Pregabalin—epilepsy syndrome	1.9e-05	0.000209	CcSEcCtD
Cyclobenzaprine—Nausea—Oxcarbazepine—epilepsy syndrome	1.9e-05	0.000209	CcSEcCtD
Cyclobenzaprine—Vision blurred—Topiramate—epilepsy syndrome	1.9e-05	0.000209	CcSEcCtD
Cyclobenzaprine—Somnolence—Pregabalin—epilepsy syndrome	1.9e-05	0.000208	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.89e-05	0.000208	CcSEcCtD
Cyclobenzaprine—Tremor—Topiramate—epilepsy syndrome	1.89e-05	0.000207	CcSEcCtD
Cyclobenzaprine—Vomiting—Lamotrigine—epilepsy syndrome	1.89e-05	0.000207	CcSEcCtD
Cyclobenzaprine—Urticaria—Valproic Acid—epilepsy syndrome	1.87e-05	0.000206	CcSEcCtD
Cyclobenzaprine—Rash—Lamotrigine—epilepsy syndrome	1.87e-05	0.000206	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Topiramate—epilepsy syndrome	1.87e-05	0.000205	CcSEcCtD
Cyclobenzaprine—Dermatitis—Lamotrigine—epilepsy syndrome	1.87e-05	0.000205	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Valproic Acid—epilepsy syndrome	1.86e-05	0.000205	CcSEcCtD
Cyclobenzaprine—Anorexia—Gabapentin—epilepsy syndrome	1.86e-05	0.000205	CcSEcCtD
Cyclobenzaprine—Headache—Lamotrigine—epilepsy syndrome	1.86e-05	0.000204	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Pregabalin—epilepsy syndrome	1.85e-05	0.000204	CcSEcCtD
Cyclobenzaprine—Agitation—Topiramate—epilepsy syndrome	1.85e-05	0.000203	CcSEcCtD
Cyclobenzaprine—Amitriptyline—OPRM1—epilepsy syndrome	1.84e-05	0.00802	CrCbGaD
Cyclobenzaprine—Fatigue—Pregabalin—epilepsy syndrome	1.84e-05	0.000202	CcSEcCtD
Cyclobenzaprine—Hypotension—Gabapentin—epilepsy syndrome	1.83e-05	0.000201	CcSEcCtD
Cyclobenzaprine—Nausea—Carbamazepine—epilepsy syndrome	1.82e-05	0.0002	CcSEcCtD
Cyclobenzaprine—Constipation—Pregabalin—epilepsy syndrome	1.82e-05	0.0002	CcSEcCtD
Cyclobenzaprine—Malaise—Topiramate—epilepsy syndrome	1.82e-05	0.0002	CcSEcCtD
Cyclobenzaprine—Vertigo—Topiramate—epilepsy syndrome	1.81e-05	0.000199	CcSEcCtD
Cyclobenzaprine—Syncope—Topiramate—epilepsy syndrome	1.81e-05	0.000199	CcSEcCtD
Cyclobenzaprine—Leukopenia—Topiramate—epilepsy syndrome	1.8e-05	0.000198	CcSEcCtD
Cyclobenzaprine—Trimipramine—ADRA2A—epilepsy syndrome	1.8e-05	0.00786	CrCbGaD
Cyclobenzaprine—Tamoxifen—ABCC2—epilepsy syndrome	1.79e-05	0.00782	CrCbGaD
Cyclobenzaprine—Promazine—CHRM2—epilepsy syndrome	1.79e-05	0.0078	CrCbGaD
Cyclobenzaprine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.78e-05	0.000196	CcSEcCtD
Cyclobenzaprine—Palpitations—Topiramate—epilepsy syndrome	1.78e-05	0.000196	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Topiramate—epilepsy syndrome	1.77e-05	0.000195	CcSEcCtD
Cyclobenzaprine—Insomnia—Gabapentin—epilepsy syndrome	1.77e-05	0.000194	CcSEcCtD
Cyclobenzaprine—Nausea—Lamotrigine—epilepsy syndrome	1.76e-05	0.000194	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Pregabalin—epilepsy syndrome	1.76e-05	0.000193	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Gabapentin—epilepsy syndrome	1.76e-05	0.000193	CcSEcCtD
Cyclobenzaprine—Convulsion—Topiramate—epilepsy syndrome	1.75e-05	0.000192	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.74e-05	0.000192	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Gabapentin—epilepsy syndrome	1.74e-05	0.000191	CcSEcCtD
Cyclobenzaprine—Hypertension—Topiramate—epilepsy syndrome	1.74e-05	0.000191	CcSEcCtD
Cyclobenzaprine—Somnolence—Gabapentin—epilepsy syndrome	1.74e-05	0.000191	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.74e-05	0.000191	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Gabapentin—epilepsy syndrome	1.72e-05	0.000189	CcSEcCtD
Cyclobenzaprine—Doxepin—ADRA2A—epilepsy syndrome	1.72e-05	0.00749	CrCbGaD
Cyclobenzaprine—Myalgia—Topiramate—epilepsy syndrome	1.72e-05	0.000188	CcSEcCtD
Cyclobenzaprine—Chest pain—Topiramate—epilepsy syndrome	1.72e-05	0.000188	CcSEcCtD
Cyclobenzaprine—Anxiety—Topiramate—epilepsy syndrome	1.71e-05	0.000188	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Gabapentin—epilepsy syndrome	1.7e-05	0.000187	CcSEcCtD
Cyclobenzaprine—Discomfort—Topiramate—epilepsy syndrome	1.7e-05	0.000186	CcSEcCtD
Cyclobenzaprine—Urticaria—Pregabalin—epilepsy syndrome	1.69e-05	0.000186	CcSEcCtD
Cyclobenzaprine—Asthenia—Valproic Acid—epilepsy syndrome	1.69e-05	0.000186	CcSEcCtD
Cyclobenzaprine—Fatigue—Gabapentin—epilepsy syndrome	1.69e-05	0.000185	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Pregabalin—epilepsy syndrome	1.69e-05	0.000185	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP2C19—epilepsy syndrome	1.68e-05	0.00733	CrCbGaD
Cyclobenzaprine—Dry mouth—Topiramate—epilepsy syndrome	1.68e-05	0.000184	CcSEcCtD
Cyclobenzaprine—Constipation—Gabapentin—epilepsy syndrome	1.67e-05	0.000184	CcSEcCtD
Cyclobenzaprine—Pruritus—Valproic Acid—epilepsy syndrome	1.67e-05	0.000183	CcSEcCtD
Cyclobenzaprine—Confusional state—Topiramate—epilepsy syndrome	1.66e-05	0.000182	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—HTR2A—epilepsy syndrome	1.66e-05	0.00722	CrCbGaD
Cyclobenzaprine—Oedema—Topiramate—epilepsy syndrome	1.65e-05	0.000181	CcSEcCtD
Cyclobenzaprine—Shock—Topiramate—epilepsy syndrome	1.62e-05	0.000178	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Valproic Acid—epilepsy syndrome	1.61e-05	0.000177	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.61e-05	0.000177	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.61e-05	0.000177	CcSEcCtD
Cyclobenzaprine—Tachycardia—Topiramate—epilepsy syndrome	1.61e-05	0.000176	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.6e-05	0.000176	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Topiramate—epilepsy syndrome	1.59e-05	0.000175	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ABCG2—epilepsy syndrome	1.59e-05	0.00691	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Pregabalin—epilepsy syndrome	1.57e-05	0.000173	CcSEcCtD
Cyclobenzaprine—Anorexia—Topiramate—epilepsy syndrome	1.57e-05	0.000172	CcSEcCtD
Cyclobenzaprine—Imipramine—CHRM2—epilepsy syndrome	1.57e-05	0.00683	CrCbGaD
Cyclobenzaprine—Dizziness—Valproic Acid—epilepsy syndrome	1.56e-05	0.000171	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR7—epilepsy syndrome	1.56e-05	0.0068	CrCbGaD
Cyclobenzaprine—Amitriptyline—CHRM2—epilepsy syndrome	1.56e-05	0.00679	CrCbGaD
Cyclobenzaprine—Urticaria—Gabapentin—epilepsy syndrome	1.55e-05	0.000171	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR7—epilepsy syndrome	1.55e-05	0.00675	CrCbGaD
Cyclobenzaprine—Abdominal pain—Gabapentin—epilepsy syndrome	1.55e-05	0.00017	CcSEcCtD
Cyclobenzaprine—Hypotension—Topiramate—epilepsy syndrome	1.54e-05	0.000169	CcSEcCtD
Cyclobenzaprine—Asthenia—Pregabalin—epilepsy syndrome	1.53e-05	0.000168	CcSEcCtD
Cyclobenzaprine—Promazine—ADRA2A—epilepsy syndrome	1.53e-05	0.00666	CrCbGaD
Cyclobenzaprine—Pruritus—Pregabalin—epilepsy syndrome	1.51e-05	0.000166	CcSEcCtD
Cyclobenzaprine—Vomiting—Valproic Acid—epilepsy syndrome	1.5e-05	0.000165	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.5e-05	0.000165	CcSEcCtD
Cyclobenzaprine—Insomnia—Topiramate—epilepsy syndrome	1.49e-05	0.000163	CcSEcCtD
Cyclobenzaprine—Rash—Valproic Acid—epilepsy syndrome	1.49e-05	0.000163	CcSEcCtD
Cyclobenzaprine—Dermatitis—Valproic Acid—epilepsy syndrome	1.49e-05	0.000163	CcSEcCtD
Cyclobenzaprine—Headache—Valproic Acid—epilepsy syndrome	1.48e-05	0.000162	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Topiramate—epilepsy syndrome	1.48e-05	0.000162	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Topiramate—epilepsy syndrome	1.47e-05	0.000161	CcSEcCtD
Cyclobenzaprine—Somnolence—Topiramate—epilepsy syndrome	1.46e-05	0.000161	CcSEcCtD
Cyclobenzaprine—Nortriptyline—SLC6A4—epilepsy syndrome	1.46e-05	0.00637	CrCbGaD
Cyclobenzaprine—Diarrhoea—Pregabalin—epilepsy syndrome	1.46e-05	0.00016	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Topiramate—epilepsy syndrome	1.45e-05	0.000159	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.44e-05	0.000158	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Topiramate—epilepsy syndrome	1.43e-05	0.000157	CcSEcCtD
Cyclobenzaprine—Fatigue—Topiramate—epilepsy syndrome	1.42e-05	0.000156	CcSEcCtD
Cyclobenzaprine—Dizziness—Pregabalin—epilepsy syndrome	1.41e-05	0.000155	CcSEcCtD
Cyclobenzaprine—Constipation—Topiramate—epilepsy syndrome	1.41e-05	0.000155	CcSEcCtD
Cyclobenzaprine—Asthenia—Gabapentin—epilepsy syndrome	1.4e-05	0.000154	CcSEcCtD
Cyclobenzaprine—Nausea—Valproic Acid—epilepsy syndrome	1.4e-05	0.000154	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP2C19—epilepsy syndrome	1.39e-05	0.00604	CrCbGaD
Cyclobenzaprine—Pruritus—Gabapentin—epilepsy syndrome	1.38e-05	0.000152	CcSEcCtD
Cyclobenzaprine—Trimipramine—SLC6A4—epilepsy syndrome	1.38e-05	0.006	CrCbGaD
Cyclobenzaprine—Vomiting—Pregabalin—epilepsy syndrome	1.36e-05	0.000149	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Topiramate—epilepsy syndrome	1.36e-05	0.000149	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.35e-05	0.000148	CcSEcCtD
Cyclobenzaprine—Rash—Pregabalin—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Cyclobenzaprine—Dermatitis—Pregabalin—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Gabapentin—epilepsy syndrome	1.34e-05	0.000147	CcSEcCtD
Cyclobenzaprine—Headache—Pregabalin—epilepsy syndrome	1.34e-05	0.000147	CcSEcCtD
Cyclobenzaprine—Amitriptyline—ADRA2A—epilepsy syndrome	1.33e-05	0.00579	CrCbGaD
Cyclobenzaprine—Doxepin—SLC6A4—epilepsy syndrome	1.31e-05	0.00571	CrCbGaD
Cyclobenzaprine—Urticaria—Topiramate—epilepsy syndrome	1.31e-05	0.000144	CcSEcCtD
Cyclobenzaprine—Trimipramine—CYP2C19—epilepsy syndrome	1.3e-05	0.00568	CrCbGaD
Cyclobenzaprine—Abdominal pain—Topiramate—epilepsy syndrome	1.3e-05	0.000143	CcSEcCtD
Cyclobenzaprine—Dizziness—Gabapentin—epilepsy syndrome	1.29e-05	0.000142	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—CYP2C19—epilepsy syndrome	1.28e-05	0.00558	CrCbGaD
Cyclobenzaprine—Nausea—Pregabalin—epilepsy syndrome	1.27e-05	0.000139	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP2C19—epilepsy syndrome	1.25e-05	0.00543	CrCbGaD
Cyclobenzaprine—Vomiting—Gabapentin—epilepsy syndrome	1.24e-05	0.000137	CcSEcCtD
Cyclobenzaprine—Doxepin—CYP2C19—epilepsy syndrome	1.24e-05	0.00542	CrCbGaD
Cyclobenzaprine—Rash—Gabapentin—epilepsy syndrome	1.23e-05	0.000135	CcSEcCtD
Cyclobenzaprine—Dermatitis—Gabapentin—epilepsy syndrome	1.23e-05	0.000135	CcSEcCtD
Cyclobenzaprine—Headache—Gabapentin—epilepsy syndrome	1.23e-05	0.000135	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Topiramate—epilepsy syndrome	1.21e-05	0.000133	CcSEcCtD
Cyclobenzaprine—Asthenia—Topiramate—epilepsy syndrome	1.18e-05	0.00013	CcSEcCtD
Cyclobenzaprine—Pruritus—Topiramate—epilepsy syndrome	1.16e-05	0.000128	CcSEcCtD
Cyclobenzaprine—Nausea—Gabapentin—epilepsy syndrome	1.16e-05	0.000128	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HTR2A—epilepsy syndrome	1.14e-05	0.00499	CrCbGaD
Cyclobenzaprine—Diarrhoea—Topiramate—epilepsy syndrome	1.13e-05	0.000124	CcSEcCtD
Cyclobenzaprine—Nortriptyline—HTR2A—epilepsy syndrome	1.12e-05	0.00489	CrCbGaD
Cyclobenzaprine—Promazine—CYP2C19—epilepsy syndrome	1.1e-05	0.00481	CrCbGaD
Cyclobenzaprine—Dizziness—Topiramate—epilepsy syndrome	1.09e-05	0.000119	CcSEcCtD
Cyclobenzaprine—Trimipramine—HTR2A—epilepsy syndrome	1.06e-05	0.00461	CrCbGaD
Cyclobenzaprine—Vomiting—Topiramate—epilepsy syndrome	1.05e-05	0.000115	CcSEcCtD
Cyclobenzaprine—Rash—Topiramate—epilepsy syndrome	1.04e-05	0.000114	CcSEcCtD
Cyclobenzaprine—Dermatitis—Topiramate—epilepsy syndrome	1.04e-05	0.000114	CcSEcCtD
Cyclobenzaprine—Headache—Topiramate—epilepsy syndrome	1.03e-05	0.000113	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP2D6—epilepsy syndrome	1.03e-05	0.00448	CrCbGaD
Cyclobenzaprine—Imipramine—SLC6A4—epilepsy syndrome	1.02e-05	0.00445	CrCbGaD
Cyclobenzaprine—Promethazine—HTR2A—epilepsy syndrome	1.02e-05	0.00444	CrCbGaD
Cyclobenzaprine—Amitriptyline—SLC6A4—epilepsy syndrome	1.01e-05	0.00442	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—epilepsy syndrome	1.01e-05	0.00439	CrCbGaD
Cyclobenzaprine—Nausea—Topiramate—epilepsy syndrome	9.77e-06	0.000107	CcSEcCtD
Cyclobenzaprine—Imipramine—CYP2C19—epilepsy syndrome	9.67e-06	0.00422	CrCbGaD
Cyclobenzaprine—Trimipramine—CYP2D6—epilepsy syndrome	9.67e-06	0.00421	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2C19—epilepsy syndrome	9.61e-06	0.00419	CrCbGaD
Cyclobenzaprine—Diphenhydramine—CYP2D6—epilepsy syndrome	9.5e-06	0.00414	CrCbGaD
Cyclobenzaprine—Promethazine—CYP2D6—epilepsy syndrome	9.31e-06	0.00406	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP2D6—epilepsy syndrome	9.25e-06	0.00403	CrCbGaD
Cyclobenzaprine—Doxepin—CYP2D6—epilepsy syndrome	9.22e-06	0.00402	CrCbGaD
Cyclobenzaprine—Promazine—HTR2A—epilepsy syndrome	8.96e-06	0.0039	CrCbGaD
Cyclobenzaprine—Carbamazepine—ABCB1—epilepsy syndrome	8.91e-06	0.00388	CrCbGaD
Cyclobenzaprine—Imipramine—HTR2A—epilepsy syndrome	7.84e-06	0.00342	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2A—epilepsy syndrome	7.79e-06	0.0034	CrCbGaD
Cyclobenzaprine—Nortriptyline—ALB—epilepsy syndrome	7.68e-06	0.00335	CrCbGaD
Cyclobenzaprine—Chlorprothixene—ABCB1—epilepsy syndrome	7.47e-06	0.00326	CrCbGaD
Cyclobenzaprine—Imipramine—CYP2D6—epilepsy syndrome	7.17e-06	0.00313	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2D6—epilepsy syndrome	7.13e-06	0.00311	CrCbGaD
Cyclobenzaprine—Trimipramine—ABCB1—epilepsy syndrome	6.91e-06	0.00301	CrCbGaD
Cyclobenzaprine—Promethazine—ABCB1—epilepsy syndrome	6.65e-06	0.0029	CrCbGaD
Cyclobenzaprine—Tamoxifen—ABCB1—epilepsy syndrome	6.6e-06	0.00288	CrCbGaD
Cyclobenzaprine—Doxepin—ABCB1—epilepsy syndrome	6.58e-06	0.00287	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM8—epilepsy syndrome	5.37e-06	0.000463	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PGF—epilepsy syndrome	5.37e-06	0.000463	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCR2—epilepsy syndrome	5.35e-06	0.000462	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—SST—epilepsy syndrome	5.35e-06	0.000462	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—ALB—epilepsy syndrome	5.33e-06	0.00232	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR7—epilepsy syndrome	5.31e-06	0.000458	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—COX3—epilepsy syndrome	5.28e-06	0.000456	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—POMC—epilepsy syndrome	5.25e-06	0.000454	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRA2A—epilepsy syndrome	5.24e-06	0.000453	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	5.2e-06	0.000449	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCL2—epilepsy syndrome	5.14e-06	0.000444	CbGpPWpGaD
Cyclobenzaprine—Imipramine—ABCB1—epilepsy syndrome	5.12e-06	0.00223	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OPRD1—epilepsy syndrome	5.12e-06	0.000442	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GNAO1—epilepsy syndrome	5.12e-06	0.000442	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	5.09e-06	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	5.09e-06	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	5.09e-06	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	5.09e-06	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	5.09e-06	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADK—epilepsy syndrome	5.09e-06	0.00044	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—ABCB1—epilepsy syndrome	5.09e-06	0.00222	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT3—epilepsy syndrome	5.06e-06	0.000437	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—BDKRB2—epilepsy syndrome	5.03e-06	0.000435	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL12—epilepsy syndrome	5.03e-06	0.000435	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	5.02e-06	0.000434	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	5.02e-06	0.000434	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	5e-06	0.000432	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PFKL—epilepsy syndrome	5e-06	0.000432	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	5e-06	0.000432	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	5e-06	0.000432	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	5e-06	0.000432	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CNR1—epilepsy syndrome	4.94e-06	0.000427	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PLCB1—epilepsy syndrome	4.92e-06	0.000425	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CHRM1—epilepsy syndrome	4.91e-06	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM1—epilepsy syndrome	4.91e-06	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDYN—epilepsy syndrome	4.91e-06	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR7—epilepsy syndrome	4.91e-06	0.000424	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	4.89e-06	0.000422	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.86e-06	0.00042	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR7—epilepsy syndrome	4.82e-06	0.000416	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	4.72e-06	0.000408	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HBEGF—epilepsy syndrome	4.68e-06	0.000404	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.66e-06	0.000402	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.66e-06	0.000402	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.66e-06	0.000402	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.66e-06	0.000402	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CDC42—epilepsy syndrome	4.61e-06	0.000399	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GAL—epilepsy syndrome	4.61e-06	0.000399	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GFAP—epilepsy syndrome	4.61e-06	0.000399	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT3—epilepsy syndrome	4.59e-06	0.000397	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	4.59e-06	0.000397	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NEU1—epilepsy syndrome	4.57e-06	0.000395	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—UPB1—epilepsy syndrome	4.57e-06	0.000395	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ATIC—epilepsy syndrome	4.57e-06	0.000395	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CHRM3—epilepsy syndrome	4.56e-06	0.000394	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP2—epilepsy syndrome	4.56e-06	0.000394	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM5—epilepsy syndrome	4.56e-06	0.000394	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	4.47e-06	0.000386	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	4.47e-06	0.000386	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AVP—epilepsy syndrome	4.47e-06	0.000386	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	4.4e-06	0.00038	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CX3CR1—epilepsy syndrome	4.37e-06	0.000378	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.33e-06	0.000374	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.33e-06	0.000374	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.32e-06	0.000373	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CX3CL1—epilepsy syndrome	4.29e-06	0.000371	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BDKRB1—epilepsy syndrome	4.29e-06	0.000371	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CHRM2—epilepsy syndrome	4.29e-06	0.000371	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	4.27e-06	0.000369	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	4.27e-06	0.000369	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GBE1—epilepsy syndrome	4.25e-06	0.000367	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	4.25e-06	0.000367	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CDC42—epilepsy syndrome	4.19e-06	0.000362	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	4.18e-06	0.000361	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GABBR1—epilepsy syndrome	4.17e-06	0.00036	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.16e-06	0.000359	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	4.09e-06	0.000353	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.07e-06	0.000352	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AVP—epilepsy syndrome	4.06e-06	0.00035	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.01e-06	0.000347	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HRH3—epilepsy syndrome	4e-06	0.000346	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	4e-06	0.000345	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.94e-06	0.00034	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OPRM1—epilepsy syndrome	3.94e-06	0.00034	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	3.89e-06	0.000336	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.86e-06	0.000333	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.86e-06	0.000333	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.86e-06	0.000333	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.86e-06	0.000333	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.86e-06	0.000333	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCR5—epilepsy syndrome	3.8e-06	0.000328	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	3.79e-06	0.000327	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	3.79e-06	0.000327	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR3—epilepsy syndrome	3.72e-06	0.000321	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.68e-06	0.000318	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NPY—epilepsy syndrome	3.62e-06	0.000313	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ATP2A2—epilepsy syndrome	3.62e-06	0.000313	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	3.62e-06	0.000312	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	3.62e-06	0.000312	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.58e-06	0.000309	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	3.54e-06	0.000306	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.53e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.53e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.53e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AGT—epilepsy syndrome	3.53e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CRH—epilepsy syndrome	3.5e-06	0.000302	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL3—epilepsy syndrome	3.5e-06	0.000302	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OXT—epilepsy syndrome	3.5e-06	0.000302	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL2—epilepsy syndrome	3.5e-06	0.000302	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HSPB1—epilepsy syndrome	3.5e-06	0.000302	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	3.47e-06	0.000299	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCR5—epilepsy syndrome	3.45e-06	0.000298	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	3.4e-06	0.000294	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.4e-06	0.000294	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.34e-06	0.000288	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.28e-06	0.000283	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.28e-06	0.000283	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.26e-06	0.000282	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTK2B—epilepsy syndrome	3.25e-06	0.000281	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TSC1—epilepsy syndrome	3.25e-06	0.000281	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.23e-06	0.000279	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.23e-06	0.000279	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AGT—epilepsy syndrome	3.2e-06	0.000277	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	3.16e-06	0.000273	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SST—epilepsy syndrome	3.16e-06	0.000273	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	3.16e-06	0.000273	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	3.13e-06	0.000271	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.12e-06	0.00027	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	3.09e-06	0.000267	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.09e-06	0.000267	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	3.08e-06	0.000266	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.03e-06	0.000262	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3e-06	0.000259	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.97e-06	0.000257	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.97e-06	0.000257	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.97e-06	0.000256	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.96e-06	0.000256	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.95e-06	0.000255	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.93e-06	0.000253	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.93e-06	0.000253	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	2.92e-06	0.000252	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	2.92e-06	0.000252	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.91e-06	0.000251	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.91e-06	0.000251	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	2.85e-06	0.000246	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.79e-06	0.000241	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.79e-06	0.000241	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	2.76e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.74e-06	0.000237	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.74e-06	0.000237	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.73e-06	0.000236	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	2.71e-06	0.000234	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	2.7e-06	0.000233	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.68e-06	0.000231	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	2.65e-06	0.000229	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	2.64e-06	0.000228	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.64e-06	0.000228	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.62e-06	0.000227	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.58e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.57e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.55e-06	0.000221	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.55e-06	0.00022	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	2.51e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.5e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	2.48e-06	0.000214	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	2.48e-06	0.000214	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.41e-06	0.000208	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	2.4e-06	0.000207	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.34e-06	0.000202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	2.27e-06	0.000196	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.23e-06	0.000193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	2.2e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.2e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.19e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.19e-06	0.000189	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.18e-06	0.000189	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.18e-06	0.000188	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.16e-06	0.000187	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.15e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.12e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.11e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.11e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	2.09e-06	0.000181	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.08e-06	0.00018	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.06e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.05e-06	0.000177	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	2.04e-06	0.000176	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.96e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.95e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.89e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.89e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.86e-06	0.000161	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.85e-06	0.00016	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.85e-06	0.00016	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.82e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.77e-06	0.000153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.75e-06	0.000151	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.75e-06	0.000151	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.74e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.74e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.72e-06	0.000149	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.71e-06	0.000148	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.71e-06	0.000148	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.69e-06	0.000146	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.68e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.67e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.65e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.59e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.56e-06	0.000135	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.53e-06	0.000132	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.51e-06	0.00013	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.45e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	0.000124	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.43e-06	0.000124	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.43e-06	0.000123	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.41e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.39e-06	0.00012	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.36e-06	0.000118	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.35e-06	0.000116	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.34e-06	0.000116	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.34e-06	0.000116	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.31e-06	0.000114	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.31e-06	0.000113	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.3e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	1.28e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.19e-06	0.000103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.18e-06	0.000102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.15e-06	9.89e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.14e-06	9.82e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.13e-06	9.75e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.12e-06	9.68e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.11e-06	9.63e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.11e-06	9.62e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.11e-06	9.55e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.08e-06	9.34e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.08e-06	9.29e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.03e-06	8.89e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.03e-06	8.87e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1e-06	8.64e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1e-06	8.64e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—POMC—epilepsy syndrome	9.57e-07	8.26e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	9.01e-07	7.78e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.77e-07	7.58e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—epilepsy syndrome	8.72e-07	7.53e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.59e-07	7.42e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	7.63e-07	6.59e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.38e-07	6.38e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.73e-07	5.81e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	6.38e-07	5.52e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.89e-07	5.09e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.53e-07	3.91e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.83e-07	3.31e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.96e-07	2.56e-05	CbGpPWpGaD
